Michelle Yanez

Insider Reports History

Entity
Individual
Location
449 S. 12 Th Street Unit 1705, Tampa, FL
Signature
/s/ Michelle Yanez
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michelle Yanez:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibitor Therapeutics, Inc. Director Common Stock 896K Apr 1, 2024 Direct
Telomir Pharmaceuticals, Inc. Chief Financial Officer Incentive Stock Options (right to buy) 200K Aug 27, 2024 Direct
MIRA PHARMACEUTICALS, INC. Chief Financial Officer Stock Options (right to buy) 150K Dec 9, 2024 Direct
MIRA PHARMACEUTICALS, INC. Chief Financial Officer Incentive Stock Option (right to buy) 57.8K Mar 26, 2024 Direct
Telomir Pharmaceuticals, Inc. Chief Financial Officer Common Stock 24.4K Jun 18, 2024 Direct

Insider Reports Filed by Michelle Yanez

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MIRA MIRA PHARMACEUTICALS, INC. Dec 9, 2024 1 $0 4 Dec 10, 2024 Chief Financial Officer
TELO Telomir Pharmaceuticals, Inc. Aug 27, 2024 1 $0 4 Sep 4, 2024 Chief Financial Officer
TELO Telomir Pharmaceuticals, Inc. Jun 18, 2024 0 $0 3 Aug 29, 2024 Chief Financial Officer
INTI Inhibitor Therapeutics, Inc. Apr 1, 2024 1 $0 4 May 16, 2024 Director
MIRA MIRA PHARMACEUTICALS, INC. Mar 26, 2024 1 $0 4 Mar 27, 2024 Chief Financial Officer
MIRA MIRA PHARMACEUTICALS, INC. Aug 17, 2023 1 $0 4 Aug 21, 2023 CFO, Secretary and Treasurer
MIRA MIRA PHARMACEUTICALS, INC. Aug 2, 2023 0 $0 3 Aug 2, 2023 CFO, Secretary & Treasurer
INTI Inhibitor Therapeutics, Inc. May 5, 2023 1 $0 4 May 17, 2023 Director
INTI Inhibitor Therapeutics, Inc. Dec 13, 2022 0 $0 3 Dec 22, 2022 Director